We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
45 hedge funds and large institutions have $237M invested in Corvus Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
156% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 9
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
45% more funds holding
Funds holding: 31 → 45 (+14)
4% more capital invested
Capital invested by funds: $228M → $237M (+$8.9M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
45
Holders Change
+14
Holders Change %
+45.16%
% of All Funds
1.2%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
23
Increased
11
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$5.01M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$2.89M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.89M |
| 4 |
JP Morgan Chase
New York
|
+$2.37M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.25M |
Top Sellers
| 1 |
SCM
Scopia Capital Management
New York
|
-$3.1M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$2.74M |
| 3 |
HI
HBK Investments
Dallas,
Texas
|
-$1.74M |
| 4 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
-$1.67M |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
-$1.55M |
